H2020
IMMUcan
Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 88 months
- Total cost
- EUR 37,187,251
- EU contribution
- EUR 17,830,000
- Participants
- 16 from 7 countries
- Topic
- H2020_IMI2-2017-13-08
- Grant agreement
- 821558
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Cliniques Universitaires Saint-Luc Asbl | BEBelgium | Participant | EUR 30,000 | VAT number (0.97) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Novigenix SA | CHSwitzerland | Participant | EUR 0 | PIC (1.00) |
| Bayer Aktiengesellschaft | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Charite - Universitaetsmedizin Berlin | DEGermany | Participant | EUR 20,000 | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Consorcio Para la Explotacion del Centro Nacional de Analisis Genomico | ESSpain | Participant | EUR 115,673 | PIC (1.00) |
| Institut de Recherche Pierre Fabre | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Institut Gustave Roussy | FRFrance | Participant | EUR 162,500 | PIC (1.00) |
| Ligue Nationale Contre le Cancer | FRFrance | Participant | EUR 40,780 | PIC (1.00) |
| Astrazeneca UK Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| King's College London | GBUnited Kingdom | Participant | EUR 765,066 | known name (0.95) |
| Abbvie Inc | USUnited States | Participant | EUR 0 | PIC (1.00) |
| Celsius Therapeutics Inc | USUnited States | Participant | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 16 participants from 7 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.